SCA
ARRY

Spearhead Capital Advisors’s Array Biopharma Inc ARRY Stock Holding History

Spearhead Capital Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,363
Closed -$202K – 109
2019
Q2 		$202K Buy
+4,363
New +$123K 0.06% 104

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Spearhead Capital Advisors's ARRY Position: Q3 2019 in Review

Spearhead Capital Advisors sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 4,363 shares — an estimated $202K sold.

Spearhead Capital Advisors first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $202K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Spearhead Capital Advisors reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Spearhead Capital Advisors sold 4,363 Array Biopharma Inc shares in Q3 2019, an estimated $202K.
  • Spearhead Capital Advisors first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Spearhead Capital Advisors's Array Biopharma Inc position peaked at $202K in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Spearhead Capital Advisors's 13F filing for Q3 2019, filed 21 Oct 2019.